Salt Composition
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Tuberculosis (TB)
Customers also bought
More About PYRA 500MG TABLET
Benefits
In Tuberculosis (TB) PYRA 500MG TABLET is used to treat tuberculosis, an infectious disease that mainly affects the lungs but can affect other parts of the body as well. It stops the growth of infection causing bacteria and helps in treating the infection. Take it in the dose and duration advised by the doctor. Your symptoms may improve before the infection is completely cured. Do not stop taking it without consulting your doctor as doing so may cause the infection to return or worsen. Follow your doctor?s instructions carefully to get maximum benefit.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. PYRA 500MG TABLET can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
PYRA 500MG TABLET is an antitubercular medicine. In the body, it gets converted to pyrazinoic acid. This pyrazinoic acid inhibits fatty acid synthase I (bacterial enzyme), which is essential for bacterial growth. Thus, it works as a bacteriocidal to prohibit their growth and treats tuberculosis.
Caution: It is important to consult your doctor regarding alcohol consumption while taking PYRA 500MG TABLET .
Seek medical advice from your doctor: PYRA 500MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: PYRA 500MG TABLET is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Seek medical advice from your doctor: It is not known whether PYRA 500MG TABLET alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Caution Advised: PYRA 500MG TABLET should be used with caution in patients with severe kidney disease. Dose adjustment of PYRA 500MG TABLET may be needed. Doctor consultation is advised. Kidney function tests are advised before you start taking this medicine.
Caution Advised: PYRA 500MG TABLET should be used with caution in patients with liver disease. Dose adjustment of PYRA 500MG TABLET may be needed. Doctor consultation is advised. Regular monitoring of liver function tests is advised before and after the start of the treatment.
What if I forget to take it?
If a dose of PYRA 500MG TABLET is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018, Maharashtra (India).
References
Gumbo T. Chemotherapy of Tuberculosis, Mycobacterium Avium Complex Disease, and Leprosy. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1554-555
Chambers HF, Deck DH. Antimycobacterial Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 827
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1171-72
Drugs.com. Pyrazinamide (31 Mar. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (29 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (31 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
